Sound waves guided by MRI aim to zap prostate tumors with fewer side effects
NCT ID NCT03814252
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tests a device that uses ultrasound energy guided by MRI to precisely destroy prostate cancer tumors while sparing healthy tissue. 62 men with localized prostate cancer will receive the treatment. The goal is to see if this approach is safe and effective at controlling the cancer while reducing common side effects like incontinence and sexual problems.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
MRI-guided transurethral ultrasound ablation (device)
What this could lead to
If successful, this could offer a precise, less invasive treatment option for localized prostate cancer with fewer side effects on urinary and sexual function.
What could go wrong
This is an early-stage study with only 62 participants, so results may not apply to all patients. Risks include potential incomplete tumor destruction or side effects from the procedure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALIZED PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Department of Urology, VSSHP, University of Turku
Turku, Finland